Trial Profile
A Phase 2, Double-blind, Parallel-group Comparative Study 2 of TS-091 in Patients with Narcolepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2022
Price :
$35
*
At a glance
- Drugs TS 091 (Primary)
- Indications Narcolepsy
- Focus Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 10 Oct 2019 Status changed from active, no longer recruiting to completed.
- 07 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Sep 2017 Status changed from not yet recruiting to recruiting.